Inspection·November 19, 2025

F 0755 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a licensed pharmacist. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview and record review, the facility failed to provide pharmaceutical services (including procedures that assure the accurate acquiring, receiving, dispensing, and administering of all drugs and biologicals) to meet the needs of 1 (Resident # 1) of 2 residents reviewed for parenteral fluids.The facility failed to ensure on 8/15/2025 that Resident # 1's intravenous medication bag was correctly labeled with the resident's name.This failure could place residents at risk for medication error and delay in medication administration.The findings included: Record review of Resident # 1's MDS assessment, dated 8/01/2025, reflected the resident was an [AGE] year-old-resident who was admitted to the facility on [DATE]. The resident had a diagnoses which included: Atrial Fibrillation (an irregular and often rapid heart rhythm in the upper chambers of the heart, called the atria), Coronary Artery Disease (a condition where the heart's blood vessels narrow or become blocked, usually due to a buildup of plaque made of fat, cholesterol, and other substances), Hypertension (high blood pressure), Wound Infection, Diabetes Mellitus (a condition where the body cannot properly use glucose, a type of sugar, for energy), Non-Alzheimer's dementia (brain conditions that cause a decline in thinking, memory, or other cognitive abilities but are not caused by Alzheimer's disease. Resident # 1's BIMS score was 03 which indicated severe cognitive impairment. Record review of Resident # 1's physician's order dated 7/29/2025 reflected an order for Meropenem intravenous Solution Reconstituted 500 MG. Use 500 MG intravenously every 6 hours for Sacral Wound Infection for 5 weeks. Start date 7/30/2025, End date 9/02/2025. Record Review of Grievance Binder reflected Grievance/Concern Report dated 8/15/2025 Name and contact information of person expressing concern: LVN A and Family member. Department concern is related to: Nursing, Description of concern: Care concern, Other: Family member had concerns regarding medication concern. Date assigned: 8/15/25, Action Taken: 1:1 Inservice completed by DNS. Was the person expressing the concern notified of the results or concern resolution: Yes, In Person. Outcome: Person/Resident satisfied with community's response to concern. Administrator's signature and dated 8/16/25. Training/Retraining form dated 8/15/2025, Topic: 5 Rights of medication administration and Utilizing the StatSafe (automated medication management system) when medications are not available, for Employee: LVN A 2-10 shift. In a phone interview on 11/17/2025 at 4:11 PM with LVN A she said Resident # 1 was on an IV antibiotic, Meropenem. She said it was a very busy day and when she picked up the medication, she only saw the name of the medicine and the dosage but did not see the resident's name. She said that the Family member was rushing me and brought it to my attention that the resident's name was different. LVN A said that at that moment she stopped the machine and notified the DON and the physician. She said there were no new orders given by the doctor. She said she also called the pharmacy to order more medication. She said, I saw that it was the right dose and the right medication, but I didn't check the label for the name. Everybody was talking to me and asking questions. She said there was medication on hand for the resident and (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 2 Event ID: 745049 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 745049 B. Wing A. Building (X3) DATE SURVEY COMPLETED 11/19/2025 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Las Alturas Nursing & Transitional Care Brownsvill 180 East Price Road Brownsville, TX 78521 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)